Skip to main content

glaucoma Archives

Novel methods to treat glaucoma

Nov. 8, 2018—Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.

Read more


Aqueous humor, microRNAs and glaucoma

Apr. 10, 2018—New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy.

Read more


Glaucoma study finds brain fights to preserve vision

Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

Read more


Cytokine linked to blindness

Jun. 30, 2017—A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Read more


Retinal neuron survival in glaucoma

Dec. 16, 2014—Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

Read more


Regenerative visual neuroscience effort launched

Oct. 2, 2014—Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

Read more


Protein boosts retinal neuron survival

Mar. 14, 2014—An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.

Read more


Team tracking new options to treat glaucoma

Sep. 19, 2013—Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.

Read more


Glaucoma patients focus of Sousan’s sharing nature

Aug. 15, 2013—Suzanne Sousan is not afraid of much.

Read more


Insights on glaucoma gene mutations

Jun. 26, 2013—Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

Read more


NIH lauds Rex’s ideas for future of vision research

Feb. 14, 2013—Tonia Rex, Ph.D., assistant professor of Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute, was recently named one of 10 winners of the National Institutes of Health competition for ideas on the future of vision research.

Read more


Glaucoma research highlighted at VEI symposium

Oct. 4, 2012—Vision experts from around the country recently gathered at the 2012 Vanderbilt Eye Institute symposium “Regenerative Medicine in Glaucoma” to discuss the impact that regenerative medicine has on neurobiological diseases.

Read more


Page 1 of 212

Recent Stories from VUMC News and Communications Publications

Our amazing skin

Vanderbilt Medicine

Our amazing skin

Biology and the beat

Vanderbilt Medicine

Biology and the beat

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

more